O-GlcNAc cycling: Implications for neurodegenerative disorders

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 11, 2009, Pages 2134-2146

  Lazarus, Brooke D ^a   Love, Dona C ^a   Hanover, John A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Glycosylation; O GlcNAc transferase; O GlcNAcase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BINDING PROTEIN; FRUCTOSE 6 PHOSPHATE; GLYCOGEN SYNTHASE KINASE 3; GRIF 1 PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; N ACETYLGLUCOSAMINE; O LINKED N ACETYLGLUCOSAMINE TRANSFERASE; OGT INTERACTING PROTEIN 106; PROTEIN P53; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; CELL ORGANELLE; CELL STRESS; DEGENERATIVE DISEASE; ENZYME ACTIVE SITE; FRONTOTEMPORAL DEMENTIA; GLYCOGEN SYNTHESIS; GLYCOSYLATION; HUMAN; INSULIN RESISTANCE; NERVE DEGENERATION; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARKINSONISM; PICK PRESENILE DEMENTIA; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; TETRATRICOPEPTIDE REPEAT; TRANSCRIPTION REGULATION;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; ANIMALS; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEURODEGENERATIVE DISEASES;

EID: 70349270677     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.03.008     Document Type: Review

References (142)

1. Ahmad I., Hoessli D.C., Walker-Nasir E., Rafik S.M., and Shakoori A.R. Nasir-ud-Din. Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation. Nucleic Acids Res 34 (2006) 175-184
2. Ahmad I., Khan T.S., Hoessli D.C., Walker-Nasir E., Kaleem A., and Shakoori A.R. Nasir-ud-Din. In silico modulation of HMGN-1 binding to histones and gene expression by interplay of phosphorylation and O-GlcNAc modification. Protein Pept Lett 15 (2008) 193-199
3. Akimoto Y., Comer F.I., Cole R.N., Kudo A., Kawakami H., Hirano H., et al. Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex. Brain Res 966 (2003) 194-205
4. Akimoto Y., Hart G.W., Hirano H., and Kawakami H. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes. Med Mol Morphol 38 (2005) 84-91
5. Al-Chalabi A., and Miller C.C. Neurofilaments and neurological disease. Bioessays 25 (2003) 346-355
6. Andrade M.A., Perez-Iratxeta C., and Ponting C.P. Protein repeats: structures, functions, and evolution. J Struct Biol 134 (2001) 117-131
7. Andrali S.S., Marz P., and Ozcan S. Ataxin-10 interacts with O-GlcNAc transferase OGT in pancreatic beta cells. Biochem Biophys Res Commun 337 (2005) 149-153
8. Andrali S.S., Qian Q., and Ozcan S. Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. J Biol Chem 282 (2007) 15589-15596
9. Arnold C.S., Johnson G.V., Cole R.N., Dong D.L., Lee M., and Hart G.W. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem 271 (1996) 28741-28744
10. Avila J., Santa-Maria I., Perez M., Hernandez F., and Moreno F. Tau phosphorylation, aggregation, and cell toxicity. J Biomed Biotechnol 2006 (2006) 74539
11. Beck M., Brickley K., Wilkinson H.L., Sharma S., Smith M., Chazot P.L., et al. Identification, molecular cloning, and characterization of a novel GABAA receptor-associated protein, GRIF-1. J Biol Chem 277 (2002) 30079-30090
12. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290 (2000) 2302-2303
13. Blard O., Frebourg T., Campion D., and Lecourtois M. Inhibition of proteasome and Shaggy/Glycogen synthase kinase-3beta kinase prevents clearance of phosphorylated tau in Drosophila. J Neurosci Res 84 (2006) 1107-1115
14. Brickley K., Smith M.J., Beck M., and Stephenson F.A. GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin. J Biol Chem 280 (2005) 14723-14732
15. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33 (2000) 95-130
16. Butkinaree C., Cheung W.D., Park S., Park K., Barber M., and Hart G.W. Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis. J Biol Chem 283 (2008) 23557-23566
17. Cheung W.D., and Hart G.W. AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J Biol Chem 283 (2008) 13009-13020
18. Cingolani G., Petosa C., Weis K., and Muller C.W. Structure of importin-beta bound to the IBB domain of importin-alpha. Nature 399 (1999) 221-229
19. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., et al. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 278 (2003) 44230-44237
20. Clarke A.J., Hurtado-Guerrero R., Pathak S., Schuttelkopf A.W., Borodkin V., Shepherd S.M., et al. Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J (2008)
21. Cohen E., and Dillin A. The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci 9 (2008) 759-767
22. Cole R.N., and Hart G.W. Glycosylation sites flank phosphorylation sites on synapsin I: O-linked N-acetylglucosamine residues are localized within domains mediating synapsin I interactions. J Neurochem 73 (1999) 418-428
23. Comer F.I., and Hart G.W. O-GlcNAc and the control of gene expression. Biochim Biophys Acta 1473 (1999) 161-171
24. Comer F.I., and Hart G.W. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40 (2001) 7845-7852
25. Comtesse N., Maldener E., and Meese E. Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem Biophys Res Commun 283 (2001) 634-640
26. Copeland R.J., Bullen Jr. J.W., and Hart G.W. Crosstalk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab (2008)
27. Cox R.T., and Spradling A.C. Milton controls the early acquisition of mitochondria by Drosophila oocytes. Development 133 (2006) 3371-3377
28. David D.C., Layfield R., Serpell L., Narain Y., Goedert M., and Spillantini M.G. Proteasomal degradation of tau protein. J Neurochem 83 (2002) 176-185
29. Dennis R.J., Taylor E.J., Macauley M.S., Stubbs K.A., Turkenburg J.P., Hart S.J., et al. Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activity. Nat Struct Mol Biol 13 (2006) 365-371
30. Dentin R., Hedrick S., Xie J., Yates Jr., and Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319 (2008) 1402-1405
31. Dias W.B., and Hart G.W. O-GlcNAc modification in diabetes and Alzheimer's disease. Mol Biosyst 3 (2007) 766-772
32. Ding M., and Vandre D.D. High molecular weight microtubule-associated proteins contain O-linked-N-acetylglucosamine. J Biol Chem 271 (1996) 12555-12561
33. Dong D.L., Xu Z.S., Hart G.W., and Cleveland D.W. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J Biol Chem 271 (1996) 20845-20852
34. Dorfmueller H.C., Borodkin V.S., Schimpl M., Shepherd S.M., Shpiro N.A., and van Aalten D.M. GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels. J Am Chem Soc 128 (2006) 16484-16485
35. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., and Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108 (2001) 1341-1348
36. Elliott E., Tsvetkov P., and Ginzburg I. BAG-1 associates with Hsc70. Tau complex and regulates the proteasomal degradation of Tau protein. J Biol Chem 282 (2007) 37276-37284
37. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69 (1992) 119-128
38. Fletcher B.S., Dragstedt C., Notterpek L., and Nolan G.P. Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. Leukemia 16 (2002) 1507-1518
39. Forsythe M.E., Love D.C., Lazarus B.D., Kim E.J., Prinz W.A., Ashwell G., et al. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc Natl Acad Sci USA 103 (2006) 11952-11957
40. Fransson S., Ruusala A., and Aspenstrom P. The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem Biophys Res Commun 344 (2006) 500-510
41. Freytag S.O., Dang C.V., and Lee W.M. Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ 1 (1990) 339-343
42. Fulop N., Feng W., Xing D., He K., Not L.G., Brocks C.A., et al. Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology (2008)
43. Gao Y., Miyazaki J., and Hart G.W. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys 415 (2003) 155-163
44. Gauthier L.R., Charrin B.C., Borrell-Pages M., Dompierre J.P., Rangone H., Cordelieres F.P., et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 (2004) 127-138
45. Gewinner C., Hart G., Zachara N., Cole R., Beisenherz-Huss C., and Groner B. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J Biol Chem 279 (2004) 3563-3572
46. Glater E.E., Megeath L.J., Stowers R.S., and Schwarz T.L. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol 173 (2006) 545-557
47. Griffith L.S., and Schmitz B. O-linked N-acetylglucosamine is upregulated in Alzheimer brains. Biochem Biophys Res Commun 213 (1995) 424-431
48. Haberhausen G., Schmitt I., Kohler A., Peters U., Rider S., Chelly J., et al. Assignment of the dystonia-parkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1. Am J Hum Genet 57 (1995) 644-650
49. Han I., and Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol 17 (1997) 2550-2558
50. Hanover J.A. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J 15 (2001) 1865-1876
51. Hanover J.A., Cohen C.K., Willingham M.C., and Park M.K. O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins. J Biol Chem 262 (1987) 9887-9894
52. Hanover J.A., Lai Z., Lee G., Lubas W.A., and Sato S.M. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells. Arch Biochem Biophys 362 (1999) 38-45
53. Hanover J.A., Forsythe M.E., Hennessey P.T., Brodigan T.M., Love D.C., Ashwell G., et al. A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc Natl Acad Sci USA 102 (2005) 11266-11271
54. Hart G.W., Housley M.P., and Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446 (2007) 1017-1022
55. Heckel D., Comtesse N., Brass N., Blin N., Zang K.D., and Meese E. Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum Mol Genet 7 (1998) 1859-1872
56. Hollstein M., Rice K., Greenblatt M.S., Soussi T., Fuchs R., Sorlie T., et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22 (1994) 3551-3555
57. Holt G.D., Snow C.M., Senior A., Haltiwanger R.S., Gerace L., and Hart G.W. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J Cell Biol 104 (1987) 1157-1164
58. Housley M.P., Rodgers J.T., Udeshi N.D., Kelly T.J., Shabanowitz J., Hunt D.F., et al. O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem 283 (2008) 16283-16292
59. Housley M.P., Udeshi N.D., Rodgers J.T., Shabanowitz J., Puigserver P., Hunt D.F., et al. A PGC-1alpha:O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem (2008)
60. Hsu C.H., Yang S.A., Wang J.Y., Yu H.S., and Lin S.R. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br J Cancer 80 (1999) 1080-1086
61. Hsu A.L., Murphy C.T., and Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300 (2003) 1142-1145
62. Iyer S.P., and Hart G.W. Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. J Biol Chem 278 (2003) 24608-24616
63. Iyer S.P., Akimoto Y., and Hart G.W. Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J Biol Chem 278 (2003) 5399-5409
64. Jinek M., Rehwinkel J., Lazarus B.D., Izaurralde E., Hanover J.A., and Conti E. The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin alpha. Nat Struct Mol Biol 11 (2004) 1001-1007
65. Johnson G.V., Jope R.S., and Binder L.I. Proteolysis of tau by calpain. Biochem Biophys Res Commun 163 (1989) 1505-1511
66. Kelly W.G., and Hart G.W. Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell 57 (1989) 243-251
67. Kelly W.G., Dahmus M.E., and Hart G.W. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem 268 (1993) 10416-10424
68. Khidekel N., Ficarro S.B., Peters E.C., and Hsieh-Wilson L.C. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. Proc Natl Acad Sci USA 101 (2004) 13132-13137
69. Kim E.J., Kang D.O., Love D.C., and Hanover J.A. Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate. Carbohydr Res 341 (2006) 971-982
70. Kim E.J., Perreira M., Thomas C.J., and Hanover J.A. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety. J Am Chem Soc 128 (2006) 4234-4235
71. Kim E.J., Amorelli B., Abdo M., Thomas C.J., Love D.C., Knapp S., et al. Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate. J Am Chem Soc 129 (2007) 14854-14855
72. Kim S.H., Kim Y.H., Song M., An S.H., Byun H.Y., Heo K., et al. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2. Biochem Biophys Res Commun 362 (2007) 325-329
73. Kornfeld R. Studies on l-glutamine d-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J Biol Chem 242 (1967) 3135-3141
74. Lairson L.L., Henrissat B., Davies G.J., and Withers S.G. Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem 77 (2008) 521-555
75. Lamarre-Vincent N., and Hsieh-Wilson L.C. Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. J Am Chem Soc 125 (2003) 6612-6613
76. Lange A., Mills R.E., Lange C.J., Stewart M., Devine S.E., and Corbett A.H. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem 282 (2007) 5101-5105
77. Lazarus B.D., Roos M.D., and Hanover J.A. Mutational analysis of the catalytic domain of O-linked N-acetylglucosaminyl transferase. J Biol Chem 280 (2005) 35537-35544
78. Lazarus B.D., Love D.C., and Hanover J.A. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates. Glycobiology 16 (2006) 415-421
79. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu Rev Neurosci 24 (2001) 1121-1159
80. Lee S.J., Sekimoto T., Yamashita E., Nagoshi E., Nakagawa A., Tanaka H., et al. Crystallization and preliminary crystallographic analysis of the importin-beta-SREBP-2 complex. Acta Crystallogr D Biol Crystallogr 59 (2003) 1866-1868
81. Lefebvre T., Ferreira S., Dupont-Wallois L., Bussiere T., Dupire M.J., Delacourte A., et al. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins-a role in nuclear localization. Biochim Biophys Acta 1619 (2003) 167-176
82. Lefebvre T., Pinte S., Guerardel C., Deltour S., Martin-Soudant N., Slomianny M.C., et al. The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated. Eur J Biochem 271 (2004) 3843-3854
83. Lefebvre T., Guinez C., Dehennaut V., Beseme-Dekeyser O., Morelle W., and Michalski J.C. Does O-GlcNAc play a role in neurodegenerative diseases?. Expert Rev Proteomics 2 (2005) 265-275
84. Li S., Armstrong C.M., Bertin N., Ge H., Milstein S., Boxem M., et al. A map of the interactome network of the metazoan C. elegans. Science 303 (2004) 540-543
85. Li S.Y., Liu Y., Sigmon V.K., McCort A., and Ren J. High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis. Diabetes Obes Metab 7 (2005) 448-454
86. Li X., Lu F., Wang J.Z., and Gong C.X. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci 23 (2006) 2078-2086
87. Licitra L., Suardi S., Bossi P., Locati L.D., Mariani L., Quattrone P., et al. Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma. J Clin Oncol 22 (2004) 4901-4906
88. Liu K., Paterson A.J., Zhang F., McAndrew J., Fukuchi K., Wyss J.M., et al. Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism. J Neurochem 89 (2004) 1044-1055
89. Liu J., Marchase R.B., and Chatham J.C. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol 42 (2007) 177-185
90. Love D.C., and Hanover J.A. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005 (2005) re13
91. Love D.C., Kochan J., Cathey R.L., Shin S.H., and Hanover J.A. Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci 116 (2003) 647-654
92. Lubas W.A., and Hanover J.A. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J Biol Chem 275 (2000) 10983-10988
93. Lubas W.A., Frank D.W., Krause M., and Hanover J.A. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem 272 (1997) 9316-9324
94. Macauley M.S., Whitworth G.E., Debowski A.W., Chin D., and Vocadlo D.J. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem 280 (2005) 25313-25322
95. Macauley M.S., Bubb A., Martinez-Fleites C., Davies G.J., and Vocadlo D.J. Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J Biol Chem (2008)
96. Marshall S. Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci STKE 2006 (2006) re7
97. Marshall S., Bacote V., and Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266 (1991) 4706-4712
98. Martinez-Fleites C., Macauley M.S., He Y., Shen D.L., Vocadlo D.J., and Davies G.J. Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation. Nat Struct Mol Biol (2008)
99. Marz P., Stetefeld J., Bendfeldt K., Nitsch C., Reinstein J., Shoeman R.L., et al. Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in the brain. J Biol Chem 281 (2006) 20263-20270
100. Mazanetz M.P., and Fischer P.M. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat Rev Drug Discov 6 (2007) 464-479
101. McClain D.A., Lubas W.A., Cooksey R.C., Hazel M., Parker G.J., Love D.C., et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99 (2002) 10695-10699
102. Miller M.W., and Hanover J.A. Functional nuclear pores reconstituted with beta 1-4 galactose-modified O-linked N-acetylglucosamine glycoproteins. J Biol Chem 269 (1994) 9289-9297
103. Morley J.F., Brignull H.R., Weyers J.J., and Morimoto R.I. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci USA 99 (2002) 10417-10422
104. Murphy J.E., Hanover J.A., Froehlich M., DuBois G., and Keen J.H. Clathrin assembly protein AP-3 is phosphorylated and glycosylated on the 50-kDa structural domain. J Biol Chem 269 (1994) 21346-21352
105. O'Donnell N., Zachara N.E., Hart G.W., and Marth J.D. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 24 (2004) 1680-1690
106. Ohn T., Kedersha N., Hickman T., Tisdale S., and Anderson P. A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly. Nat Cell Biol 10 (2008) 1224-1231
107. Park S.Y., Ryu J., and Lee W. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Exp Mol Med 37 (2005) 220-229
108. Pawar A.P., Dubay K.F., Zurdo J., Chiti F., Vendruscolo M., and Dobson C.M. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol 350 (2005) 379-392
109. Rafiq I., da Silva Xavier G., Hooper S., and Rutter G.A. Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. J Biol Chem 275 (2000) 15977-15984
110. Rao F.V., Dorfmueller H.C., Villa F., Allwood M., Eggleston I.M., and van Aalten D.M. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis. EMBO J 25 (2006) 1569-1578
111. Rex-Mathes M., Werner S., Strutas D., Griffith L.S., Viebahn C., Thelen K., et al. O-GlcNAc expression in developing and ageing mouse brain. Biochimie 83 (2001) 583-590
112. Robertson L.A., Moya K.L., and Breen K.C. The potential role of tau protein O-glycosylation in Alzheimer's disease. J Alzheimers Dis 6 (2004) 489-495
113. Roos M.D., and Hanover J.A. Structure of O-linked GlcNAc transferase: mediator of glycan-dependent signaling. Biochem Biophys Res Commun 271 (2000) 275-280
114. Roos M.D., Su K., Baker J.R., and Kudlow J.E. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol Cell Biol 17 (1997) 6472-6480
115. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 10 suppl. (2004) S10-S17
116. Schindowski K., Belarbi K., and Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 7 suppl. 1 (2008) 43-56
117. Schultz J., and Pils B. Prediction of structure and functional residues for O-GlcNAcase, a divergent homologue of acetyltransferases. FEBS Lett 529 (2002) 179-182
118. Schweers O., Schonbrunn-Hanebeck E., Marx A., and Mandelkow E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J Biol Chem 269 (1994) 24290-24297
119. Shaw P., Freeman J., Bovey R., and Iggo R. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12 (1996) 921-930
120. Sikorski R.S., Boguski M.S., Goebl M., and Hieter P. A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell 60 (1990) 307-317
121. Slawson C., Housley M.P., and Hart G.W. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J Cell Biochem 97 (2006) 71-83
122. Smith M.J., Pozo K., Brickley K., and Stephenson F.A. Mapping the GRIF-1 binding domain of the kinesin, KIF5C, substantiates a role for GRIF-1 as an adaptor protein in the anterograde trafficking of cargoes. J Biol Chem 281 (2006) 27216-27228
123. Sohn K.C., Lee K.Y., Park J.E., and Do S.I. OGT functions as a catalytic chaperone under heat stress response: a unique defense role of OGT in hyperthermia. Biochem Biophys Res Commun 322 (2004) 1045-1051
124. Stone J., de Lange T., Ramsay G., Jakobovits E., Bishop J.M., Varmus H., et al. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol 7 (1987) 1697-1709
125. Stowers R.S., Megeath L.J., Gorska-Andrzejak J., Meinertzhagen I.A., and Schwarz T.L. Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36 (2002) 1063-1077
126. Tallent M.K., Varghis N., Skorobogatko Y., Hernandez-Cuebas L., Whelan K., Vocadlo D.J., et al. In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation. J Biol Chem 284 (2009) 174-181
127. Taylor R.P., Parker G.J., Hazel M.W., Soesanto Y., Fuller W., Yazzie M.J., et al. Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase. J Biol Chem 283 (2008) 6050-6057
128. Toleman C., Paterson A.J., Whisenhunt T.R., and Kudlow J.E. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J Biol Chem 279 (2004) 53665-53673
129. Tsokos G.C., Nambiar M.P., and Juang Y.T. Activation of the Ets transcription factor Elf-1 requires phosphorylation and glycosylation: defective expression of activated Elf-1 is involved in the decreased TCR zeta chain gene expression in patients with systemic lupus erythematosus. Ann N Y Acad Sci 987 (2003) 240-245
130. Vosseller K., Wells L., Lane M.D., and Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 99 (2002) 5313-5318
131. Vousden K.H. p53: death star. Cell 103 (2000) 691-694
132. Wells L., Gao Y., Mahoney J.A., Vosseller K., Chen C., Rosen A., et al. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem 277 (2002) 1755-1761
133. Whelan S.A., Lane M.D., and Hart G.W. Regulation of the O-GlcNAc transferase by insulin signaling. J Biol Chem (2008)
134. Whisenhunt T.R., Yang X., Bowe D.B., Paterson A.J., Van Tine B.A., and Kudlow J.E. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16 (2006) 551-563
135. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., and Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA 98 (2001) 6611-6616
136. Yang X., Zhang F., and Kudlow J.E. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110 (2002) 69-80
137. Yang W.H., Kim J.E., Nam H.W., Ju J.W., Kim H.S., Kim Y.S., et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8 (2006) 1074-1083
138. Yang X., Ongusaha P.P., Miles P.D., Havstad J.C., Zhang F., So W.V., et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451 (2008) 964-969
139. Yuzwa S.A., Macauley M.S., Heinonen J.E., Shan X., Dennis R.J., He Y., et al. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 4 (2008) 483-490
140. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J.J., Marth J.D., and Hart G.W. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 279 (2004) 30133-30142
141. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
142. Zhang F., Hu Y., Huang P., Toleman C.A., Paterson A.J., and Kudlow J.E. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 282 (2007) 22460-22471